MITOSENSE
Mitosense is a biotechnology company operating in stealth mode. It was established in Great Falls, Virginia in 2019.
MITOSENSE
Industry:
Biotechnology Lifestyle
Founded:
2019-01-01
Address:
Great Falls, Virginia, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
703-298-7315
Similar Organizations
Petragen
Petragen is a biotechnology company located in Davie, Florida.
More informations about "Mitosense"
Harnessing the Power of Mitochondria to Fight Disease | MitoSense
MitoSense is an R&D company with exclusively licensed and patent pending technology to replenish mitochondria to fight disease, including neurodegenerative disorders such as ALS, Alzheimer’s and Parkinson’s.See details»
About Us - MitoSense
We are an R&D company with exclusively licensed and patent pending technology to replenish mitochondria to fight disease, including neurodegenerative disorders such as ALS, Alzheimer’s …See details»
Mitosense - Crunchbase Company Profile & Funding
Mitosense is a biotechnology company developing treatments for neurodegenerative diseases. It was established in Great Falls, Virginia in 2019. Products and ServicesSee details»
MitoSense Company Profile 2024: Valuation, Funding & Investors
Operator of a medical research company intended to develop treatments for neurodegenerative diseases. The company utilizes Mitochondria Organelle Transplantation (MOT) technology to …See details»
MitoSense, Inc. - LinkedIn
We are an R&D company with exclusively licensed and patent pending technology to replenish mitochondria to fight disease, including neurodegenerative disorders such as ALS, …See details»
Mitosense - Funding, Financials, Valuation & Investors - Crunchbase
Mitosense is a biotechnology company developing treatments for neurodegenerative diseases.See details»
MitoSense - VentureRadar
MitoSense is a biotechnology company that has developed and exclusively licensed a patent-pending technology called Mitochondria Organelle Transplantation (MOTâ„¢).See details»
MitoSense Officially Joins CAMP as Partner for Advanced Therapy ...
Jul 24, 2023 · MitoSense, Inc. is a leading biotechnology company focused on developing advanced therapies for neurodegenerative diseases using Mitochondria Organelle …See details»
MitoSense Raises $3.5M to Treat Neurodegenerative …
Jan 22, 2024 · MitoSense, a biotechnology company focused on neurodegenerative disease treatments, announced a $3.5 million seed round led by Caydan Capital Partners. The company aims to replenish damaged …See details»
MitoSense Joins CAMP as Partner for Advanced Therapy Medicinal …
Jul 24, 2023 · MitoSense, Inc. is a leading biotechnology company focused on developing advanced therapies for neurodegenerative diseases using Mitochondria Organelle …See details»
MitoSense Closes $3.5M in Seed Funding - FinSMEs
Jan 22, 2024 · MitoSense, a Plymouth, MA-based research and development company focused on neurodegenerative disease treatments, raised $3.5M in Seed funding. The round was led …See details»
Partners Aim to Treat ALS by Restoring Mitochondria, Cell Energy
Jan 4, 2023 · MitoSense has developed a patented, first-in-kind mitochondria transplantation technology — coined Mitochondria Organelle Transplantation (MOT) — that enables the …See details»
MitoSense Inc. Completes $3.5 Million Series Seed Funding Round, …
PLYMOUTH, Mass., Jan. 22, 2024 /PRNewswire/ -- MitoSense Inc., a research and development company focused on neurodegenerative disease treatments, announces the successful …See details»
MITOSENSE AND UPPSALA UNIVERSITY'S CENTRE FOR …
Dec 21, 2022 · MitoSense, Inc.'s medical technology is focused on harnessing the power of mitochondria to treat a variety of diseases. Mitochondria Organelle Transplantation (MOTâ„¢) …See details»
MitoSense Inc. and Uppsala University, in Collaboration with Elliott ...
Jan 25, 2024 · MitoSense Inc. has been a front-runner in developing advanced therapies for neurodegenerative diseases. Its patented MOTâ„¢ technology has shown promising results in …See details»
Our Technology - MitoSense
MitoSense has exclusively licensed and patent-pending technology known as Mitochondria Organelle Transplantation (MOTTM ) to replenish mitochondria to fight disease with a primary …See details»
MitoSense Inc. Completes $3.5 Million Series Seed Funding Round, …
Jan 22, 2024 · MitoSense aims to replenish damaged mitochondria in humans afflicted with degenerative conditions, initially concentrating on Amyotrophic Lateral Sclerosis (ALS) treatment.See details»
MitoSense Inc. and Uppsala University, in Collaboration with
Jan 25, 2024 · MitoSense Inc. in collaboration with Uppsala University, Elliott Mitochondrial Center, and the Sallie Astor Burdine Breast Foundation in Baton Rouge, Louisiana, USA, …See details»
MitoSense is Accepted into NVIDIA's Inception Program
Jul 29, 2024 · We are thrilled to announce that MitoSense Inc. has been accepted into the prestigious NVIDIAInception Program! This milestone marks a significant step forward in our …See details»
MITOSENSE AND U.S. DEPARTMENT OF VETERANS AFFAIRS …
Sep 12, 2022 · With exclusively licensed and patent-pending technology known as Mitochondria Organelle Transplantation (MOTâ„¢ ) to replenish mitochondria to fight disease, MitoSense is …See details»